Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Things Amgen Inc.'s Management Just Said That You'll Want to Know


3 Things Amgen Inc.'s Management Just Said That You'll Want to Know

It's been a great 2017 for Amgen (NASDAQ: AMGN) shareholders so far. Amgen stock is up close to 30%. The company announced several positive developments from its pipeline. Still, though, some questions remain about what's next for the big biotech.

Amgen CEO Robert Bradway and CFO David Meline sat down on Tuesday at the Morgan Stanley healthcare conference to answer some of those questions. Here are three things the Amgen executives said that investors will want to know. 

Image source: Getty Images.

Continue reading


Source: Fool.com

Astrazeneca ADR Aktie

74,00 €
0,00 %
Gleichstand beim Astrazeneca ADR Kurs: Keine Veränderung zu beobachten.

Like: 0
AZN
Teilen

Kommentare